InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
VANCOUVER, British Columbia, June 06, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
News
Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity
COMPANY ANNOUNCEMENT – NO. 27/ 2022 Zealand Pharma Presents Data from Phase 1 Trial of…
Jellyworks Inc CEO Alex Lineton to Attend Exclusive Adobe Event in London England
Vancouver, British Columbia–(Newsfile Corp. – June 6, 2022) – Jellyworks Inc (the “Company” or “Jellyworks”)…
Infinity Stone Announces Work Program at Zen-Whoberi Copper-Cobalt-Platinum-Palladium Project
Vancouver, British Columbia–(Newsfile Corp. – June 6, 2022) – Infinity Stone Ventures Corp. (CSE: GEMS)…
For Every Special Occasion and Celebration, Yowie Puts the SURPRISE in Party
NEW YORK, NY, Jun 7, 2022 – (ACN Newswire) – Yowie Group, the confectionary company…
ENERGY TRANSFER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Energy Transfer LP and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
Redwood Trust Prices Upsized $200 Million Convertible Senior Notes Offering
MILL VALLEY, Calif.–(BUSINESS WIRE)–Redwood Trust, Inc. (NYSE: RWT; “Redwood” or the “Company”), a leader in…
NTT SECURITY HOLDINGS RELEASES ITS 2022 GLOBAL THREAT INTELLIGENCE REPORT
NTT SECURITY HOLDINGS RELEASES ITS 2022 GLOBAL THREAT INTELLIGENCE REPORT NTT SECURITY HOLDINGS RELEASES ITS…
Elevar Therapeutics Shares Results of Phase 2 Rivoceranib Trial in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma
CHICAGO, June 06, 2022 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company…
Imago BioSciences to Host Virtual Investor Event
– Company to host virtual investor event on Saturday, June 11 at 10:30 AM ET…
Werewolf Therapeutics to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
Immunovant to Report Fourth Quarter and Full Year 2022 Financial Results on June 8, 2022
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
Editas Medicine Reports Inducement Grants to New Chief Executive Officer
CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading…
Checkpoint Therapeutics Announces Presentation of Pivotal Trial Results of Cosibelimab at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
WALTHAM, Mass., June 06, 2022 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (Checkpoint) (NASDAQ: CKPT), a…
Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022
Researchers from the Dr. Piotr Witkowski Laboratory at the University of Chicago presented updated data…
Delta 9 Announces Overnight Marketed Public Offering of Units for $2 Million
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES WINNIPEG, Manitoba,…
Vaccitech to Present at the Jefferies Healthcare Conference
OXFORD, United Kingdom, June 06, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…
Vincerx Pharma Provides Key Strategic Update
Prioritizing Phase 1b VIP152 studies to focus on double-hit DLBCL and CLL Continuing to advance…
Tempest to Present at the Jefferies Healthcare Conference
SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
Lobe Sciences Announces Share Consolidation
Vancouver, British Columbia–(Newsfile Corp. – June 6, 2022) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB:…